Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.
Tracy Williams
Advertisement
Tracy Williams is senior director ADME/Toxicology/PKPD, Eli Lilly and Co.
Articles by Tracy Williams
Advertisement
Latest Updated Articles
Enabling the Virtual Human Through Physiologically-based Pharmacokinetic ModelingPublished: March 16th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
2
Orion and Abzena Collaboration Highlights Integrated Antibody Manufacturing Advances
3
BioPharm Weekly News Roundup—Week of Oct. 20, 2025
4
